PS02.187: RELATIONSHIP BETWEEN REGIONAL LYMPH NODE SIZE AND PROGNOSIS IN ESOPHAGEAL CANCER PATIENTS

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 175-175
Author(s):  
Teruyuki Kobayashi ◽  
Makoto Yamasaki ◽  
Koji Tanaka ◽  
Tomoki Makino ◽  
Yasuhiro Miyazaki ◽  
...  

Abstract Background Surgery for esophageal cancer, in many cases performed after chemotherapy or chemoradiotherapy. Because treatment policy is determined by pretreatment evaluation, improvement of diagnosis accuracy is important. Commonly, metastatic diagnosis is performed by uniformly defining the size. We examined whether evaluation of N classification reflecting more prognosis can be done by examining lymph node metastasis criteria by area in CT. Methods We surveyed 300 cases of thoracic esophageal cancer (squamous cell carcinoma) who underwent surgery at our hospital from September 2010 to December 2014. We defined lymph node with a minor axis of 5 mm or more from CT (5 mm slice) before treatment as ‘visible node’. We changed the cut off of lymph node short diameter for each area to 5 mm, 10 mm and 15 mm, and those with long diameter/short diameter ratio less than 1.5 were designated as ‘metastasis’. We examined the optimal size of lymph node which reflect prognosis. We compared the correlation with the prognosis based on the N category of the 8th edition UICC TNM classification and the 11th edition Japanese Classification of Esophageal Cancer, using the cutoff of short diameter examined for each area. Results We evaluated the cut off of each area lymph node except paraesophageal, 15 mm in the cervical, 10 mm in the recurrent nerve, 15 mm in the upper trachea, 15 mm in the lower trachea, and 10 mm in the epigastric. Classification based on the N classification of the 8th edition UICC TNM classification, overall survival declined in the order of N categories. Conclusion From this result, it was suggested that diagnosis based on lymph node size in CT reflects prognosis by prescribing cut off for each site. From now on, it would be possible to raise the diagnostic accuracy of N classification further by subdivision of cut off and accumulation of the case. Disclosure All authors have declared no conflicts of interest.

2002 ◽  
Vol 9 (10) ◽  
pp. 1010-1016 ◽  
Author(s):  
Dipok Kumar Dhar ◽  
Mitsuo Tachibana ◽  
Naoko Kinukawa ◽  
Maruyama Riruke ◽  
Hitoshi Kohno ◽  
...  

2011 ◽  
Vol 47 ◽  
pp. S450-S451
Author(s):  
M. Nomura ◽  
K. Shitara ◽  
T. Kodaira ◽  
A. Mizota ◽  
C. Kondoh ◽  
...  

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e14500-e14500
Author(s):  
Motoo Nomura ◽  
Kohei Shitara ◽  
Takeshi Kodaira ◽  
Chihiro Kondoh ◽  
Daisuke Takahari ◽  
...  

e14500 Background: The 7th edition of the American Joint Committee on Cancerstaging system does not include lymph node size in the guidelines for staging patients with esophageal cancer. The objectives of this study were to determine the prognostic impact of the largest lymph node diameter (ND) on survival and to develop and validate a new staging system for patients with esophageal squamous cell cancer who were treated with definitive chemoradiotherapy (CRT). Methods: Information on 402 patients with esophageal cancer undergoing CRT at 2 institutions was reviewed. Univariate and multivariate analyses of data from 1 institution were used to assess the impact of clinical factors on survival, and recursive partitioning analysis was performed to develop the new staging classification. To assess its clinical utility, the new classification was validated using data from the second institution. Results: According to RPA, ND stages were best when classified as ND0 (the absence of lymph node metastases), ND1 (< 2.8 cm), and ND2 (≥ 2.8 cm). By multivariate analysis, gender, T, N, and ND stages were independently and significantly associated with survival (p<0.05). The resulting new staging classification showed the following: T1-2ND0 as Group I; T3-4ND0 or T1-2ND1 as Group II; T3-4ND1 as Group III; and TanyND2 as Group IV. The 4 new stages led to good separation of survival curves in both the developmental and validation datasets (p<0.05). Conclusions: Our results showed that lymph node size is a strong independent prognostic factor and that the new staging system, which incorporated lymph node size, provided good prognostic power and discriminated effectively for patients with esophageal cancer undergoing CRT.


2021 ◽  
Vol 555 ◽  
pp. 81-88
Author(s):  
Atsushi Igarashi ◽  
Takashi Kato ◽  
Hiromi Sesaki ◽  
Miho Iijima

Sign in / Sign up

Export Citation Format

Share Document